GSA Capital Partners’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-124,773
| Closed | -$65K | – | 2010 |
|
|
2024
Q4 | $65K | Buy |
124,773
+16,361
| +15% | +$8.52K | ﹤0.01% | 1524 |
|
|
2024
Q3 | $351K | Buy |
108,412
+297
| +0.3% | +$962 | 0.03% | 1144 |
|
|
2024
Q2 | $324K | Buy |
108,115
+4,794
| +5% | +$14.4K | 0.02% | 1229 |
|
|
2024
Q1 | $480K | Sell |
103,321
-81,252
| -44% | -$377K | 0.04% | 908 |
|
|
2023
Q4 | $764K | Sell |
184,573
-10,842
| -6% | -$44.9K | 0.06% | 545 |
|
|
2023
Q3 | $586K | Sell |
195,415
-76,109
| -28% | -$228K | 0.05% | 697 |
|
|
2023
Q2 | $668K | Buy |
271,524
+208,926
| +334% | +$514K | 0.07% | 556 |
|
|
2023
Q1 | $141K | Sell |
62,598
-59,992
| -49% | -$135K | 0.01% | 1315 |
|
|
2022
Q4 | $428K | Buy |
+122,590
| New | +$428K | 0.05% | 698 |
|
|
2022
Q1 | – | Sell |
-17,429
| Closed | -$393K | – | 1773 |
|
|
2021
Q4 | $393K | Buy |
+17,429
| New | +$393K | 0.05% | 753 |
|